In our study, the CXCL5-rs425535 variant A allele was associated with a decreased risk of breast cancer in AA premenopausal women, but not EAs, and was much more common among AA (MAF= 39.7%) than among EA women (MAF=13.5%). Here, CXCL5 is linked to breast cancer.